Overview

Stannsoporfin With Light Therapy for Newborn Babies With Jaundice

Status:
Completed
Trial end date:
2016-03-22
Target enrollment:
Participant gender:
Summary
It is normal for red blood cells to die, even in newborn babies. The waste from that is called bilirubin. The liver clears bilirubin out of the body. Some babies are born with illness that makes red blood cells die too fast, so the liver is not strong enough to keep up with it. The yellowish color in eyes or skin means there is too much bilirubin in the body. It can be dangerous if a baby's bilirubin gets too high. Special lights are put on jaundiced babies (called phototherapy) to help the liver get rid of bilirubin. This study tests an experimental drug to see if it can help the liver even more, by safely cutting down the amount of bilirubin the body is making in the first place.
Phase:
Phase 2
Details
Lead Sponsor:
InfaCare Pharmaceuticals Corporation
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Treatments:
Tin mesoporphyrin